Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
CAPREIT Announces April 2025 Distribution
-
ERES Declares April 2025 Monthly Distribution
-
Peyto Exploration & Development Corp. Confirms Monthly Dividend for May 15, 2025
-
Rivalry Announces Application for a Management Cease Trade Order for Late Filing of Annual Filings
-
Intermap Presenting at the Planet MicroCap Showcase on April 23, 2025
-
Stride Announces Date for Third Quarter Fiscal Year 2025 Earnings Call
-
Crushon AI Unlocks Unfiltered NSFW AI With Longest Memory
-
Southside Bancshares, Inc. Announces First Quarter Earnings Call
-
Paul Mueller Company Announces Second Expansion to Its Components Products Facilities
-
Bridger Aerospace Strengthens Board with the Addition of Meghan Pasricha as Independent Director
-
SPX Technologies Announces Acquisition of Sigma & Omega
-
Provident Bank’s Community Partnership Program Donates Over $931,000 to Local Non-Profits Since 2006
-
Banzai Reports Fourth Quarter and Full Year 2024 Financial Results
-
Ascension Seton to Take Full Ownership of Cedar Park Medical Center, Strengthening Patient-Centered Care
-
Rackspace Technology to Announce First Quarter 2025 Earnings on May 8, 2025
-
Patria Announces First Quarter 2025 Investor Call
-
LPL Financial Announces Promotion of Five Executives to New Managing Director Roles
-
Ostin Technology Group Announces Pricing of $5.0 million Registered Direct Offering
-
Montauk Renewables, Inc. Announces Share Repurchase Program
-
Decent Holding Inc. to Hold Extraordinary General Meeting on May 9, 2025
-
Eightco announces Full-Year 2024 Financial Results
-
Enterprise Bancorp, Inc. Announces Quarterly Dividend
-
Carlyle Secured Lending, Inc. Schedules Earnings Release and Quarterly Earnings Call to Discuss its Financial Results for the First Quarter Ended March 31, 2025
-
Jamf to Report First Quarter 2025 Financial Results on May 6, 2025
-
Artisan Partners Asset Management Inc. to Announce 1Q25 Results on April 29, 2025
-
QuoteMedia Announces Financial Results for 2024
-
Kling AI Advances to the 2.0 Era, Empowering Everyone to Tell Great Stories with AI
-
Vishay Intertechnology to Announce First Quarter Results on Wednesday, May 7
-
Mercury Systems to Report Third Quarter Fiscal Year 2025 Financial Results on May 6, 2025
-
TEN Ltd. Announces the Filing of Form 20-F With the SEC
-
Navitas Announces Automotive Qualification of High-Power GaNSafe™ ICs
-
LanzaTech Announces Fourth-Quarter and Full-Year 2024 Financial Results
-
Janover CEO to Speak at Canaccord Genuity’s 5th Annual Digital Assets Symposium
-
KRONOS WORLDWIDE, INC. ANNOUNCES EXPECTED FIRST QUARTER 2025 EARNINGS RELEASE DATE
-
COMPX ANNOUNCES EXPECTED FIRST QUARTER 2025 EARNINGS RELEASE DATE
-
NL INDUSTRIES ANNOUNCES EXPECTED FIRST QUARTER 2025 EARNINGS RELEASE DATE
-
VALHI ANNOUNCES EXPECTED FIRST QUARTER 2025 EARNINGS RELEASE DATE
-
Protara Therapeutics Announces Appointment of Leonardo Viana Nicacio, M.D., as Chief Medical Officer
-
Milestone Scientific Reports Year-End 2024 Financial Results and Reports Strong Outlook for 2025
-
Cardiff Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Toro Corp. Announces Availability of its 2024 Annual Report on Form 20-F
-
Diginex Limited and AIKYA Announce Strategic Alliance to Launch diginexESG in Malaysia, Advancing ESG Reporting and Sustainable Finance
-
Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med
-
ARRAY Technologies, Inc. Announces First Quarter 2025 Earnings Release Date and Conference Call
-
New York Mortgage Trust 2025 First Quarter Conference Call Scheduled for Thursday, May 1, 2025
-
Tvardi Therapeutics Announces Closing of Merger with Cara Therapeutics
-
Wireless Industry Veteran Ryan Sullivan Joins Inseego as Senior Vice President of Carrier Product Management
-
NeuroNOS Appoints Nobel Prize Laureate, Professor Dan Shechtman, to Scientific Advisory Board
-
SPAR Group, Inc. Continues Work on Annual Report on Form 10-K for Fiscal Year ended December 31, 2024
-
Cardiff Oncology Announces Completion of Enrollment in Phase 2 CRDF-004 Trial Evaluating Onvansertib for the Treatment of First-line RAS-mutated Metastatic Colorectal Cancer

